# Population-based screening for colorectal cancer in Wuhan, China

**Authors:** Song Liu, Yifan Wang, Yuying Wang, Chaofan Duan, Fan Liu, Heng Zhang, Xia Tian, Xiangwu Ding, Manling Zhang, Dan Cao, Yi Liu, Ruijingfang Jiang, Duan Zhuo, Jiaxi Peng, Shida Zhu, Lijian Zhao, Jian Wang, Li Wei, Zhaohong Shi

PMC · DOI: 10.3389/fonc.2024.1284975 · Frontiers in Oncology · 2024-02-29

## TL;DR

A large study in Wuhan, China, shows that a non-invasive fecal DNA test can effectively detect colorectal cancer and precancerous lesions in a population-based screening program.

## Contribution

This study provides real-world evidence of fecal DNA test effectiveness for population-based CRC screening in China.

## Key findings

- 4.5% of 98,683 subjects tested positive for colorectal cancer or precancerous lesions using a fecal DNA test.
- The test detected CRC at a rate of 1.3% and advanced precancerous lesions at 2.3%.
- 28.0% of colonoscopies showed colorectal neoplasms without pathological confirmation.

## Abstract

Fecal DNA test has emerged as a non-invasive alternative for colorectal cancer (CRC) screening in average-risk population. However, there is currently insufficient evidence in China to demonstrate the effectiveness of population-based CRC screening using fecal DNA based test. Here, a large-scale real-world study for CRC screening was implemented in Wuhan, Hubei province, China. A total of 98,683 subjects aged between 45 and 60 years were screened by a fecal DNA test (ColoTect®) which detected methylation status of SDC2, ADHFE1, and PPP2R5C. Participants who tested positive were advised to receive diagnostic colonoscopy. 4449 (4.5%) subjects tested positive for fecal DNA test, and 3200 (71.9%) underwent colonoscopy. Among these, 2347 (73.3%) had abnormal colonoscopy findings, of which 1330 (56.7%) subjects received pathological diagnosis. Detection rates for CRC and advanced precancerous lesions were 1.3% and 2.3%, respectively. Detection rates for nonadvanced adenomas and polyps were 14.0% and 21.6%, respectively. 28.0% of all colonoscopies showed colorectal neoplasm but lack pathological diagnosis. 6.1% showed other abnormalities such as enteritis. In conclusion, preliminary real-world evidence suggested that fecal DNA tests had promising diagnostic yield in population-based CRC screening.

https://www.chictr.org.cn/showproj.html?proj=192838, identifier ChiCTR2300070520.

## Linked entities

- **Diseases:** colorectal cancer (MONDO:0005575)

## Full-text entities

- **Genes:** ADHFE1 (alcohol dehydrogenase iron containing 1) [NCBI Gene 137872] {aka ADH8, HMFT2263, HOT}, PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma) [NCBI Gene 5527] {aka B56G, B56gamma, HJS4, PR61G}, SDC2 (syndecan 2) [NCBI Gene 6383] {aka CD362, HSPG, HSPG1, SYND2}
- **Diseases:** CRC (MESH:D015179), adenomas (MESH:D000236), precancerous lesions (MESH:D011230), polyps (MESH:D011127), enteritis (MESH:D004751)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10937563/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10937563/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC10937563/full.md

---
Source: https://tomesphere.com/paper/PMC10937563